About C2 Pharma
C2 Pharma is a company based in Luxembourg (Luxembourg) founded in 2014 by Andrew Badrot. It operates as a B2B, and Wholesale Distribution. C2 Pharma offers products and services including Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and Digoxin. C2 Pharma operates in a competitive market with competitors including AnalytiCon Discovery, Magellan BioScience Group, Celtarys, BJ Biochem and Metagreen, among others.
- Headquarter Luxembourg, Luxembourg
- Founders Andrew Badrot
-
Sectors
HealthcareChemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name C-Squared Pharma India Private Limited
- Date of Incorporation 09 Apr, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$0 (USD)0as on Mar 31, 2022
-
Net Profit
$-3.58 K (USD)76.1as on Mar 31, 2022
-
EBITDA
$-3.01 K (USD)79.92as on Mar 31, 2022
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of C2 Pharma
C2 Pharma offers a comprehensive portfolio of products and services, including Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and Digoxin. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Active ingredient used in pharmaceuticals for eye treatments.
Compound for ophthalmic applications in eye care.
Ingredient for glaucoma and ocular hypertension treatments.
Used in eye examinations and dilation procedures.
Cardiac medication for heart failure management.
Enhanced form of digoxin for improved absorption.
Agent for eye dilation in ophthalmic procedures.
Variant for eye care and related applications.
Treatment for reducing intraocular pressure.
Decongestant for nasal and eye relief.
Local anesthetic for eye surgeries.
Medication for glaucoma eye treatment.
Alternative form for eye condition management.
Agent for pupil dilation in eye exams.
Unlock access to complete
Funding Insights of C2 Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by C2 Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - C2 Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
C2 Pharma Comparisons
Competitors of C2 Pharma
C2 Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnalytiCon Discovery, Magellan BioScience Group, Celtarys, BJ Biochem and Metagreen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Natural products chemistry is specialized in by AnalytiCon Discovery.
|
|
| domain | founded_year | HQ Location |
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
|
|
| domain | founded_year | HQ Location |
Company that develops and commercializes novel fluorescent probes and ligands for fluorescence-based methods in drug discovery
|
|
| domain | founded_year | HQ Location |
Research and development services for sugar derivatives are provided.
|
|
| domain | founded_year | HQ Location |
Develops technologies to harness compounds from natural production.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on C2 Pharma
Frequently Asked Questions about C2 Pharma
When was C2 Pharma founded?
C2 Pharma was founded in 2014.
Where is C2 Pharma located?
C2 Pharma is headquartered in Luxembourg, Luxembourg.
Who is the current CEO of C2 Pharma?
Andrew Badrot is the current CEO of C2 Pharma. They have also founded this company.
What does C2 Pharma do?
C2 Pharma is a pharmaceutical group established in 2014 that specializes in manufacturing and distributing active pharmaceutical ingredients and complex chemical compounds from natural and synthetic sources. It operates through a global network, including locations in Ireland, Luxembourg, USA, Germany, and India. The company focuses on ophthalmic and niche APIs, supporting research, development, and supply chain activities for various partners in the pharmaceutical industry.
Who are the top competitors of C2 Pharma?
C2 Pharma's top competitors include AnalytiCon Discovery, BJ Biochem and Magellan BioScience Group.
What products or services does C2 Pharma offer?
C2 Pharma offers Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and 6 more products and services.